OTC: LMMY
Exousia Bio, Inc.CIK 0001939937 · Other · SIC 8200 · Educational Services
Effective December 6, 2024, there occurred a change in control of the Company. On such date, pursuant to two separate stock purchase agreements (the “Change-in-Control Agreements”), Zhang Shengwu acquired a total of 5,250,000 shares of the Company’s common stock (the “Acquired Shares”), 5,000,000… About this business →
Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.
Sign up freeWant to see a complete report first? Today's free report (GTM 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade LMMY commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Jun 16, 2026 (period ending Feb 28, 2026). SEC XBRL (companyfacts) — not generated by the model.
Consolidated Statements of Operations (Unaudited)
| Description | Nine months ended Feb 28, 2026 | Q2 ended Nov 30, 2025 |
|---|---|---|
| Revenue: | ||
| Total revenue / net sales | — | — |
| Cost of revenue / cost of sales | 0.06 | 0.06 |
| Gross profit | (0.06) | (0.06) |
| Operating expenses: | ||
| General and administrative | — | |
| Total operating expenses | 0.2 | 0.2 |
| Operating income | (0.3) | (0.2) |
| Other income/(expense), net | 0.2 | 0.2 |
| Income before income taxes | (0.05) | (0.02) |
| Income tax expense/(benefit) | — | — |
| Net income | (0.05) | (0.02) |
| Basic earnings per share | — | — |
| Diluted earnings per share | — | — |
Consolidated Balance Sheets (Unaudited)
| Description | Feb 28, 2026 | Nov 30, 2025 |
|---|---|---|
| Current assets: | ||
| Accounts receivable, net | — | — |
| Total current assets | — | — |
| Property, plant and equipment, net | — | — |
| Identifiable intangible assets, net | — | — |
| Deferred income taxes and other assets | 22.1 | 22.1 |
| TOTAL ASSETS | 22.1 | 22.1 |
| Current liabilities: | ||
| Accounts payable | 0.2 | 0.2 |
| Accrued liabilities | — | — |
| Other current liabilities | 0.05 | 0.05 |
| Total current liabilities | 0.3 | 0.3 |
| Total liabilities | 0.3 | 0.3 |
| Shareholders' equity: | ||
| Common stock | 0.01 | 0.01 |
| Capital in excess of stated value | 22.1 | 22.1 |
| Retained earnings (deficit) | (0.3) | (0.3) |
| Total shareholders' equity | 21.8 | 21.8 |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 22.1 | 22.1 |
Consolidated Statements of Cash Flows (Unaudited)
| Description | Nine months ended Feb 28, 2026 | Six months ended Nov 30, 2025 |
|---|---|---|
| Operating Activities: | ||
| Net cash from operating activities | 0.2 | 0.2 |
| Investing Activities: | ||
| Net cash from investing activities | (22.1) | (22.1) |
| Financing Activities: | ||
| Net cash from financing activities | 21.9 | 21.9 |
Amounts in millions USD; EPS as reported. Line labels are presentation-friendly mappings of filer XBRL tags — not a re-audit of the full statements. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗
About Exousia Bio, Inc.
Source: Item 1 (Business) from the 10-K filed October 17, 2025. Description as filed by the company with the SEC.
Item 1. Business
Recent Change in Control
Effective December 6, 2024, there
occurred a change in control of the Company. On such date, pursuant to two separate stock purchase agreements (the “Change-in-Control
Agreements”), Zhang Shengwu acquired a total of 5,250,000 shares of the Company’s common stock (the “Acquired Shares”),
5,000,000 of the Acquired Shares from Dwight Witmer and 250,000 of the Acquired Shares from Stephen Townsend. The Acquired Shares represent
approximately 67.51% of the outstanding shares of the Company’s common stock and constitute voting control of the Company.
The total consideration paid by
Mr. Shengwu for the Acquired Shares was $335,910 in cash, $318,410 to Mr. Witmer and $17,500 to Mr. Townsend.
In conjunction with the Change-in-Control
Agreements, on December 6, 2024, Dwight Witmer resigned as a Director, CEO, CFO and Secretary of the Company, Stephen Townsend resigned
as a Director and COO of the Company and Zhang Shengwu was appointed as the Sole Director, President, Chief Executive Officer and Secretary
of the Company.
Background
The
Company was incorporated in Wyoming in January of 2022.
The
Company’s Registration Statement on Form S-1 was declared effective by the Securities and Exchange Commission on February 13, 2023.
This was followed by our initial offering of shares of the Company’s common stock. The initial offering concluded in May of 2023.
Business
Strategies
We
are a startup developing a business taping the eLearning market and the gaming market by teaching financial knowledge and resource management
to children. The product is to be delivered through an educational platform and, in particular, a video game marketed as twoplus1®
which for a competitive subscription fee will provide an immersive learning experience in finance and real estate. The game will a number
of revenue-generating features deployed in the game, including a possibility to trade virtual property from which LAMY intends to generate
monetary commissions.
Read full description ↓
Our
business has not suffered any bankruptcy, receivership or similar proceeding at any time. There have not been any material reclassification,
merger, consolidation, or purchase or sale of a significant amount of assets in or out of the ordinary course of business.
The
business model of our Company is deploying new technologies and trying to use innovations to reduce costs, gain competitive advantages
to significantly affect the overcoming the inertia of developing economies. The relatively small costs for starting our business, ease
of launching and being “closer” to the client than larger companies lower the barrier to creating and penetrating into the
already narrow niche of numerous competitors in our target markets.
We
are not in need for any government approval of principal products or services we provide.
Intellectual Properties
We
have trademark protected of twoplus1® brand in the United Kingdom and are in the process
of doing the same in other key regions.
1